EUR 22.9
(0.44%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 178.1 Million EUR | -96.87% |
2022 | 567.32 Million EUR | 9.31% |
2021 | 519.01 Million EUR | 19.6% |
2020 | 433.94 Million EUR | 11.5% |
2019 | 389.17 Million EUR | 7.0% |
2018 | 363.72 Million EUR | 5.92% |
2017 | 343.4 Million EUR | 3.13% |
2016 | 333 Million EUR | 10.29% |
2015 | 301.94 Million EUR | 14.6% |
2014 | 263.47 Million EUR | 22.03% |
2013 | 215.91 Million EUR | 16.83% |
2012 | 184.8 Million EUR | 11.0% |
2011 | 166.49 Million EUR | 10.1% |
2010 | 151.21 Million EUR | 6.87% |
2009 | 141.49 Million EUR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 96.5 Million EUR | 0.0% |
2023 Q4 | 85.71 Million EUR | 0.0% |
2023 FY | 17.74 Million EUR | -96.87% |
2023 Q2 | 17.88 Million EUR | 0.0% |
2022 Q2 | 27.61 Million EUR | 0.0% |
2022 Q4 | 31.89 Million EUR | 0.0% |
2022 FY | 567.32 Million EUR | 9.31% |
2021 Q2 | 22.33 Million EUR | 0.0% |
2021 Q4 | 35.84 Million EUR | 0.0% |
2021 FY | 519.01 Million EUR | 19.6% |
2020 FY | 433.94 Million EUR | 11.5% |
2020 Q2 | 16.99 Million EUR | 0.0% |
2020 Q4 | 21.91 Million EUR | 0.0% |
2019 Q2 | 16.02 Million EUR | 0.0% |
2019 FY | 389.17 Million EUR | 7.0% |
2019 Q4 | 14.54 Million EUR | 0.0% |
2018 Q2 | 71.03 Million EUR | 0.0% |
2018 Q4 | 59.53 Million EUR | 0.0% |
2018 FY | 363.72 Million EUR | 5.92% |
2017 Q2 | 63.59 Million EUR | 0.0% |
2017 FY | 343.4 Million EUR | 3.13% |
2017 Q4 | 53.73 Million EUR | 0.0% |
2016 Q2 | 58.93 Million EUR | 0.0% |
2016 Q4 | 65.03 Million EUR | 0.0% |
2016 FY | 333 Million EUR | 10.29% |
2015 Q4 | 58.6 Million EUR | 0.0% |
2015 Q2 | 55.61 Million EUR | 0.0% |
2015 FY | 301.94 Million EUR | 14.6% |
2014 Q2 | 48.49 Million EUR | 0.0% |
2014 Q4 | 55.61 Million EUR | 0.0% |
2014 FY | 263.47 Million EUR | 22.03% |
2013 Q4 | 45.21 Million EUR | 0.0% |
2013 FY | 215.91 Million EUR | 16.83% |
2013 Q2 | 38 Million EUR | 0.0% |
2012 Q2 | - EUR | 0.0% |
2012 Q4 | - EUR | 0.0% |
2012 FY | 184.8 Million EUR | 11.0% |
2011 FY | 166.49 Million EUR | 10.1% |
2011 Q4 | - EUR | 0.0% |
2011 Q2 | - EUR | 0.0% |
2010 FY | 151.21 Million EUR | 6.87% |
2010 Q4 | - EUR | 0.0% |
2009 FY | 141.49 Million EUR | 0.0% |
2009 Q4 | - EUR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Cegedim SA | 235.64 Million EUR | 24.418% |
Guerbet SA | 550.79 Million EUR | 67.663% |
Nexus AG | 44.98 Million EUR | -295.928% |
Bastide Le Confort Médical SA | 1.91 Million EUR | -9205.538% |
Revenio Group Oyj | 18.8 Million EUR | -847.383% |
Drägerwerk AG & Co. KGaA | 1.28 Billion EUR | 86.177% |
Sartorius Aktiengesellschaft | 1.02 Billion EUR | 82.581% |
Siemens Healthineers AG | 5.59 Billion EUR | 96.819% |
Medios AG | 23.03 Million EUR | -673.206% |
Equasens Société anonyme | 14.67 Million EUR | -1114.097% |
Stratec SE | 41.95 Million EUR | -324.501% |